Infection with Dengue virus (DENV)is a growing concern in solid organ transplant (SOT) recipients in endemic regions. We report a 15‐year‐old kidney transplant recipient who developed fever and thrombocytopenia on post‐transplant day five; DENV NS1 antigen confirmed acute infection. He recovered with supportive care, and no donor‐derived transmission was identified. A review of 327 cases shows early post‐transplant dengue carries higher risks of cytopenias, capillary leak, graft dysfunction, and mortality (6.1%) versus the general population. Improved diagnostics, outbreak‐responsive donor screening, and pre‐transplant vaccination in immunocompetent candidates may help mitigate dengue burden in SOT recipients.
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: